| Financial Year |
March 31 2023 |
| Monetary Funds |
407,492,697.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
88,386,481.61 |
| Advances to Suppliers |
6,754,564.77 |
| Other Receivables |
695,172,138.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,919,177.62 |
| Total Current Assets |
1,204,725,059.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,374,870.51 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
235,392.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
109,793.24 |
| Deferred Income Tax Assets |
12,785,403.36 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
128,556,976.91 |
| Total Assets |
1,333,282,036.87 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
44,616,076.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,362,284.26 |
| Taxes Payable |
7,572,373.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
71,491,138.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,927,112.38 |
| Other Current Liabilities |
24,940,330.79 |
| Sub-Total of Current Liabilities |
175,831,639.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,521,485.85 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,127,170.31 |
| Total Liabilities |
201,958,809.78 |
| Paid-In Capital(Or Share Stock) |
729,797,652.00 |
| Capital Surplus |
91,536,086.09 |
| Surplus Reserve |
55,133,853.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
254,855,635.46 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,131,323,227.09 |
| Owner's Equity（Stockholder's Equity） |
1,131,323,227.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,333,282,036.87 |
